ARTL Stock Analysis: Buy, Sell, or Hold?
ARTL - Artelo Biosciences, Inc. Common Stock
$10.54
7.35 (230.41%)
▲
5d:
+32.25%
30d:
+750.0%
90d:
+567.09%
WAIT
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 12, 2026
Get Alerted When ARTL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ARTL is 75.4% above fair value ($6.01). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ARTL is 75.4% above fair value ($6.01). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ARTL is currently trading at $10.54, which is considered extended relative to its 30-day fair value range of $0.71 to $6.01.
Technical Outlook: Technically, ARTL is in a uptrend. Immediate support is located at $2.96, while resistance sits at $14.96. The stock is showing strong short-term momentum, up 230.4% recently.
Market Sentiment: ARTL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.00 (+70.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARTL is in a uptrend. Immediate support is located at $2.96, while resistance sits at $14.96. The stock is showing strong short-term momentum, up 230.4% recently.
Market Sentiment: ARTL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.00 (+70.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.71 -
$6.01
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+75.4% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+230.4%)
- BULLISH: Trading 70.8% below Wall St target ($18.00)
- WARNING: Recommendation downgraded due to 75.4% overvaluation
Fair Price Analysis
30-Day Fair Range
$0.71 -
$6.01
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$2.96
Resistance Level
$14.96
Current Trend
Uptrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.21
Wall Street Target
$18.00
(+70.8%)
Share & Embed Analysis
Last updated: March 30, 2026 8:25 AM ET
Data refreshes hourly during market hours. Next update: 9:25 AM
Data refreshes hourly during market hours. Next update: 9:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARTL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 54 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 53 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 53 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 60 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$547 | 42 HOLD |
